News

AddToAny

Google+ Facebook Twitter Twitter

"Don't delay cancer treatment"

A European Society for Medical Oncology (ESMO) interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published.

It encourages medical oncologists worldwide not to discontinue or delay any type of anti-cancer treatment that may potentially impact on overall survival. The experts also urge an end to labelling all cancer patients as vulnerable to coronavirus infection, since this may lead to inappropriate care and potential negative outcomes.

Earlier this year, ESMO developed guidelines for prioritising the various aspects of cancer care across different tumour types, with the aim to mitigate the negative effects of the pandemic on the management of cancer patients.  

bit.ly/2EC1oH3


Picture Credit | iStock

Related Articles

Making the transition

Leah Riley, Histology Manager at Royal Devon and Exeter Hospital, explains why and how her team ditched paper and the issues they overcame on their journey to a greener laboratory.

Label-free histopathology

A research team has developed a machine learning-based label-free histopathology device that can perform histopathology in real time.

“No urgent referral for 60% of red flags”

Six out of 10 patients in England with “red flag” symptoms indicative of possible cancer didn’t receive an urgent referral for specialist assessment within two weeks, as recommended in clinical guidelines.

The British Journal of Biomedical Science: Issue 4, 2021, synopsis

Editor Anthony Rhodes provides a brief glimpse of the articles on offer in the fourth issue of 2021.

Top